Medical Diagnostics

GE HealthCare Launches Revolution™ Vibe CT with AI and One-Beat Cardiac Imaging

Advanced CT Technology Enhances Speed, Precision, and Cardiac Imaging Capabilities Advanced CT Technology Enhances Speed, Precision, and Cardiac Imaging Capabilities ...

Visby Medical Gains FDA De Novo Authorization for First OTC PCR Sexual Health Test

Groundbreaking Approval Expands Access to Rapid, At-Home STI Diagnostics ...

NodeAI Wins Falcons' Fortunes 2025 for AI Lung Cancer Diagnostics

Hamilton-Based Startup Recognized for Groundbreaking AI Innovation in Early Cancer Detection...

Indian MedTech Leader Remidio invests in UK’s Occuity to Enhance Non-Invasive Global Disease Screening

Strategic Partnership to Advance Early Disease Detection with Cutting-Edge Optical Technology...

Newronika’s AlphaDBS Secures CE Mark for Adaptive Deep Brain Stimulation System

Next-generation closed-loop DBS device now approved in Europe, offering real-time, personalized neuromodulation for Parkinson’s and other neurological disorders....

Immunovia’s Next-Gen Blood Test Outperforms CA19-9 in Detecting Early-Stage Pancreatic Cancer

New results from the VERIFI study show Immunovia's test accurately detects 77% of early-stage cases and maintains strong specificity across diverse high-risk groups—strengthening commercial launch plans for Q3 2025....

South Korea’s Noul Highlights AI Cervical Cancer Diagnostic Platform at NVIDIA GTC 2025

Joining NVIDIA’s Healthcare & Life Sciences ecosystem, Noul showcases miLab™ CER—its on-device, cloud-free solution tackling diagnostic gaps in cervical cancer and beyond....

VolitionRx Unveils Promising Data: Nu.Q® Immunoassay Detects 21 Cancers, Eyes Multi-Licensing Deals

With low false positives and broad detection capabilities, Volition’s Nu.Q® test could reshape the $20B liquid biopsy market, as the company advances licensing talks with major diagnostic players. ...

SynerFuse™ and Velentium Medical to Scale Innovative e-TLIF™ Implant Procedure After Successful Proof-of-Concept

Next-generation therapy integrates neuromodulation with spinal fusion to improve outcomes and reduce opioid reliance for over 500,000 spinal surgery patients annually in the U.S....

Clario Expands Neuroscience Capabilities with Acquisition of NeuroRx

Strategic move strengthens Clario’s leadership in medical imaging and bolsters expertise in multiple sclerosis and neurological drug development....